121 related articles for article (PubMed ID: 401003)
21. Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: A systematic review.
Goedhard LE; Stolker JJ; Heerdink ER; Nijman HL; Olivier B; Egberts TC
J Clin Psychiatry; 2006 Jul; 67(7):1013-24. PubMed ID: 16889443
[TBL] [Abstract][Full Text] [Related]
22. [General methodological problems of psychotropic drug trials (author's transl)].
Heimann H
Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):119-29. PubMed ID: 360236
[TBL] [Abstract][Full Text] [Related]
23. Comparison of descriptive variables for symptomatic volunteers and clinical patients with anxiety disorders.
Rapaport MH; Frevert T; Babior S; Seymour S; Zisook S; Kelsoe J; Judd LL
Anxiety; 1996; 2(3):117-22. PubMed ID: 9160612
[TBL] [Abstract][Full Text] [Related]
24. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS; Gerevich J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):756-60. PubMed ID: 17289236
[TBL] [Abstract][Full Text] [Related]
25. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
26. Multicenter clinical trials: methodological aspects.
Ban TA; Wilson WH
Mod Probl Pharmacopsychiatry; 1981; 16():9-20. PubMed ID: 7322136
[No Abstract] [Full Text] [Related]
27. A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders.
Rapaport MH; Zisook S; Frevert T; Seymour S; Kelsoe JR; Judd LL
J Clin Psychopharmacol; 1996 Jun; 16(3):242-6. PubMed ID: 8784657
[TBL] [Abstract][Full Text] [Related]
28. Medical drug use by women: symptoms and change attributions.
Lapp JE; Marinier R; Pihl RO
Int J Addict; 1983 Jan; 18(1):45-51. PubMed ID: 6826266
[TBL] [Abstract][Full Text] [Related]
29. A comparison of descriptive characteristics of male outpatients and inpatients with affective disorders.
Mendlowicz MV; Rapaport MH; Thompson P; Kelsoe JR; Golshan S; Judd LL; Gillin JC
Int Clin Psychopharmacol; 1998 Nov; 13(6):245-52. PubMed ID: 9861574
[TBL] [Abstract][Full Text] [Related]
30. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
31. Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample.
Coyne JC; Palmer SC; Shapiro PJ; Thompson R; DeMichele A
Gen Hosp Psychiatry; 2004; 26(2):121-8. PubMed ID: 15038929
[TBL] [Abstract][Full Text] [Related]
32. The prescribing of psychotropic drugs in mental health services in Trinidad.
Moore S; Jaime LK; Maharajh H; Ramtahal I; Reid S; Ramsewak FS; Maharaj M
Rev Panam Salud Publica; 2002 Sep; 12(3):207-14. PubMed ID: 12396640
[TBL] [Abstract][Full Text] [Related]
33. Perceived anxiety, depression, and sleeping problems in relation to psychotropic drug use among elderly in assisted-living facilities.
Holmquist IB; Svensson B; Höglund P
Eur J Clin Pharmacol; 2005 May; 61(3):215-24. PubMed ID: 15761757
[TBL] [Abstract][Full Text] [Related]
34. Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old people in geriatric care in 2000 and 2007.
Lövheim H; Gustafson Y; Karlsson S; Sandman PO
Int Psychogeriatr; 2011 Dec; 23(10):1616-22. PubMed ID: 21902862
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(4):1-39. PubMed ID: 28515818
[TBL] [Abstract][Full Text] [Related]
36. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
Grolleau A; Cougnard A; Bégaud B; Verdoux H
Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
[TBL] [Abstract][Full Text] [Related]
37. The impact of treatment-resistant depression on health care utilization and costs.
Crown WH; Finkelstein S; Berndt ER; Ling D; Poret AW; Rush AJ; Russell JM
J Clin Psychiatry; 2002 Nov; 63(11):963-71. PubMed ID: 12444808
[TBL] [Abstract][Full Text] [Related]
38. Improvement of phase III psychotropic drug trials by intensive phase II work.
Klein DF
Neuropsychopharmacology; 1991 Jun; 4(4):251-8; discussion 259-71. PubMed ID: 1867735
[TBL] [Abstract][Full Text] [Related]
39. [A psychotropic drug treatment of psychiatric symptoms after stroke].
Shimoda K; Kimura M
Nihon Rinsho; 2012 Jan; 70(1):89-93. PubMed ID: 22413499
[TBL] [Abstract][Full Text] [Related]
40. Prescription of psychotropic drugs in patients with chronic renal failure on hemodialysis.
Yeh CY; Chen CK; Hsu HJ; Wu IW; Sun CY; Chou CC; Lee CC; Wang LJ
Ren Fail; 2014 Nov; 36(10):1545-9. PubMed ID: 25154717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
